Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Cerilliant
US Department of Justice
Deloitte
Fish and Richardson
Citi
McKesson
Johnson and Johnson
Novartis

Generated: January 24, 2018

DrugPatentWatch Database Preview

CITALOPRAM HYDROBROMIDE Drug Profile

« Back to Dashboard

Which patents cover Citalopram Hydrobromide, and when can generic versions of Citalopram Hydrobromide launch?

Citalopram Hydrobromide is a drug marketed by Mylan Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Silarx, West-ward Pharms Int, Biovail Labs Intl, Actavis Elizabeth, Amneal Pharms Ny, Aurobindo, Cipla Ltd, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, G And W Labs Inc, Glenmark Generics, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Pliva, Roxane, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, Teva Pharms, Torpharm, Torrent Pharms, and Watson Labs. and is included in thirty-three NDAs.

The generic ingredient in CITALOPRAM HYDROBROMIDE is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
Drug patent expirations by year for CITALOPRAM HYDROBROMIDE
Pharmacology for CITALOPRAM HYDROBROMIDE
Medical Subject Heading (MeSH) Categories for CITALOPRAM HYDROBROMIDE

US Patents and Regulatory Information for CITALOPRAM HYDROBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077052-001 Jul 3, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Invagen Pharms CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077534-002 Oct 3, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Epic Pharma Llc CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077036-002 Oct 28, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077034-001 Jun 30, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077042-002 Nov 5, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077041-001 Nov 23, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Generics CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 205407-003 Dec 23, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077039-003 Feb 3, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077141-002 Apr 10, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077041-002 Nov 23, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Healthtrust
QuintilesIMS
Harvard Business School
Express Scripts
Moodys
Merck
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot